KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Capital Expenditures: 2009-2024

Historic Capital Expenditures for Chemed (CHE) over the last 16 years, with FY2024 value amounting to $49.5 million.

  • Chemed's Capital Expenditures rose 2815.8% to $17.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $59.7 million, marking a year-over-year increase of 2205.87%. This contributed to the annual value of $49.5 million for FY2024, which is 1288.04% down from last year.
  • Chemed's Capital Expenditures amounted to $49.5 million in FY2024, which was down 1288.04% from $56.9 million recorded in FY2023.
  • Chemed's Capital Expenditures' 5-year high stood at $58.8 million during FY2020, with a 5-year trough of $49.5 million in FY2024.
  • Its 5-year average for Capital Expenditures is $56.2 million, with a median of $57.3 million in 2022.
  • In the last 5 years, Chemed's Capital Expenditures soared by 1095.58% in 2020 and then plummeted by 1288.04% in 2024.
  • Annual analysis of 5 years shows Chemed's Capital Expenditures stood at $58.8 million in 2020, then dropped by 0.27% to $58.7 million in 2021, then dropped by 2.3% to $57.3 million in 2022, then fell by 0.82% to $56.9 million in 2023, then decreased by 12.88% to $49.5 million in 2024.
  • Its Capital Expenditures stands at $49.5 million for FY2024, versus $56.9 million for FY2023 and $57.3 million for FY2022.